RETRACTED ARTICLE: PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation

[1]  R. Haribalaganesh,et al.  High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels. , 2009, Microvascular research.

[2]  K. Suzuma,et al.  Novel role of erythropoietin in proliferative diabetic retinopathy. , 2007, Diabetes research and clinical practice.

[3]  Y. Yoon,et al.  Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Peter F M Choong,et al.  PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. , 2006, Trends in molecular medicine.

[5]  W. Jiang,et al.  Pigment Epithelium-derived Factor Inhibits Angiogenesis via Regulated Intracellular Proteolysis of Vascular Endothelial Growth Factor Receptor 1* , 2006, Journal of Biological Chemistry.

[6]  T. Imaizumi,et al.  Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. , 2005, Life sciences.

[7]  Emelyn H. Shroff,et al.  Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. , 2005, Cancer research.

[8]  B. Gong,et al.  Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells. , 2005, Biochemical and biophysical research communications.

[9]  C. Jie,et al.  How PEDF prevents angiogenesis: a hypothesized pathway. , 2005, Medical hypotheses.

[10]  A. Yoshimura,et al.  Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation , 2004 .

[11]  G. Lang,et al.  Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia. , 2004, The Journal of endocrinology.

[12]  A. Yoshimura,et al.  Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. , 2004, Journal of molecular and cellular cardiology.

[13]  O. Volpert,et al.  Migration Inhibitory Factor Mediates Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol Kinase , 2003, Circulation research.

[14]  Xiaojing Su,et al.  Isolation and characterization of murine retinal endothelial cells. , 2003, Molecular vision.

[15]  M. Díaz-Ricart,et al.  Erythropoietin Triggers a Signaling Pathway in Endothelial Cells and Increases the Thrombogenicity of their Extracellular Matrices In Vitro , 2002, Thrombosis and Haemostasis.

[16]  M. Matsumura,et al.  Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. , 2002, American journal of ophthalmology.

[17]  O. Volpert,et al.  Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. , 2002, American journal of ophthalmology.

[18]  M. Matsumura,et al.  Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. , 2002, American journal of ophthalmology.

[19]  O. Volpert,et al.  Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor , 2002, Nature Medicine.

[20]  G. Gao,et al.  Tipping the balance for angiogenic disorders. , 2002, Drug discovery today.

[21]  H. Hammes,et al.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. , 2001, Diabetes.

[22]  I. Morita,et al.  Novel mechanism for age‐related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF , 2001, Journal of cellular physiology.

[23]  Jian-xing Ma,et al.  Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization , 2001, FEBS letters.

[24]  N. Bouck,et al.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Vogt,et al.  Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Zeiher,et al.  Akt takes center stage in angiogenesis signaling. , 2000, Circulation research.

[27]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[28]  D. Ribatti,et al.  Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 1999, Blood.

[29]  N. Bouck,et al.  Multiple forms of angiostatin induce apoptosis in endothelial cells. , 1998, Blood.

[30]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[31]  V. Dixit,et al.  Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[32]  V. Dixit,et al.  Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A 1 in Vascular Endothelial Cells * , 1998 .

[33]  D. Baltimore,et al.  Interleukin 3-dependent survival by the Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[35]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[36]  T. Tsuruo,et al.  Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. , 1996, European journal of biochemistry.

[37]  D. Donner,et al.  Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction That Contain SH2 Domains , 1995, The Journal of Biological Chemistry.

[38]  R. Carlini,et al.  Recombinant human erythropoietin stimulates angiogenesis in vitro. , 1995, Kidney international.

[39]  A. Anagnostou,et al.  Erythropoietin receptor mRNA expression in human endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Michael S. Pepper,et al.  The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth , 1994, Nature.

[41]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.